Peripheral Interventions News Today

HeartBeam, Inc. (NASDAQ:BEAT) Q3 2023 Earnings Call Transcript November 14, 2023 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.12. Operator: Greetings and welcome to the HeartBeam Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation. As a reminder, this conference is […]

Operator: Greetings and welcome to the HeartBeam Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation.

Arkansas Heart Hospital has added Dr. Hamza Rayes, an interventional cardiologist specializing in coronary and peripheral interventions, to its team of cardiologists.

SANTA CLARA, Calif.--(BUSINESS WIRE)--Nov 14, 2023--

Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices 

With global staffing issues and the supply situation gradually improving, Boston Scientific's (BSX) international business is expected to have improved further in the third quarter.

Avinger Announces Presentations by Key Opinion Leaders at AMP (The ...

[224 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global Deflectable Catheters Market...

Further Strengthens Board of Directors and IP Position, Publishes First Peer-Reviewed Article Management to Host Webcast and Conference Call Today At 4:30 p.m. ET ... -Today at 04:03 pm- MarketScreener

Renowned Vascular Physician and Researcher Brings Wealth of Clinical and Industry Experience to Board ...